U.S. Stocks Decline Amid Mixed Earnings, Valeant's Volatile RideBy and
Biotech shares slide as Valeant Pharmaceuticals plunges
General Motors rallies, Chipotle slumps after results
U.S. stocks declined after Valeant Pharmaceuticals International Inc. took health-care stocks on a wild ride, distracting investors from one of the busiest days for corporate earnings so far this season.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.